Category: Zacks Small Cap Research

13456713650 / 1352 POSTS
By David Bautz, PhD NASDAQ:MDNA READ THE FULL MDNA RESEARCH REPORT Business Update CTA Submitted, Phase 1/2 Clinical Trial of MDNA11 to Start in 3Q21 In June 2021, Medicenna Therapeutics Corp. (NASDAQ:MDNA) announced it has submitted a Clinical Trial ...
By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 16, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced its second quarter 2021 operational and financial results and ...
By John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT Second Quarter Financial and Operational Review Protalix Biotherapeutics, Inc. (NYSE:PLX) announced its 2Q:21 financial and operational results in an August 16, 2021 press release a ...
By Lisa Thompson OTC:LGIQ READ THE FULL LGIQ RESEARCH REPORT Logiq (OTC:LGIQ) beat our revenue estimates for the quarter with its pick up in revenues at AppLogiq. We had expected the quarter to be down sequentially due to the exceptionally strong qua ...
By M. Marin NASDAQ:SQFT READ THE FULL SQFT RESEARCH REPORT Presidio Property Trust (NASDAQ:SQFT), an internally-managed REIT that has a diversified portfolio of commercial and industrial properties and model homes, reported 2Q21 results last week. Sa ...
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Preclinical Studies for BARDA Contract Underway In June 2021, MediciNova, Inc. (NASDAQ:MNOV) announced it initiated a sheep study and also reached an agreement to cond ...
By Lisa Thompson OTC:NEXCF READ THE FULL NEXCF RESEARCH REPORT By the end of the month NexTech (OTC:NEXCF) should close on the acquisition of UK-based spatial computing company ARWAY in a US$1 million all-stock transaction (approximately 625,00 ...
By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT Business Update Enrollment Continuing in Phase 2b FORTRESS Trial Virios Therapeutics, Inc. (NASDAQ:VIRI) is currently conducting the Phase 2b FORTRESS (Fibromyalgia Outcome Research T ...
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Second Quarter 2021 Operational & Financial Results Dyadic International Inc. (NASDAQ:DYAI) released second quarter 2021 operational and financial results on August 12, 202 ...
By Lisa Thompson OTC:BRGGF READ THE FULL BRGGF RESEARCH REPORT Bragg (OTC:BRGGF) reported Q2 earnings and gave updated guidance and detailed information about every aspect of its business. Investors had been waiting for insight into the German market ...
13456713650 / 1352 POSTS